drug · small molecule
cebranopadol
Phase 3updated 3mo agoby Tris Pharma Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
Nociceptin receptorOpioid receptors; mu/kappa/delta
all catalysts(0)
nothing on the calendar yet
Trials studying cebranopadol
- phase3A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
- phase3A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
- phase1A Study to Assess the Abuse Potential of Intranasal Cebranopadol
- phase1Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that